ASMLs, Trifecta

ASML's Trifecta: Earnings, Geopolitics, and a Record Order Converge

13.04.2026 - 12:02:49 | boerse-global.de

ASML reports Q1 results amid new US bill targeting chip equipment sales to China. Analysts warn of potential 15% revenue hit, but a massive €38B backlog provides a buffer.

ASML's Trifecta: Earnings, Geopolitics, and a Record Order Converge - Foto: über boerse-global.de

A pivotal nine-day stretch for ASML Holding NV kicks off this Wednesday, blending high-stakes financial reporting with escalating geopolitical tensions. The Dutch semiconductor equipment giant faces a market test as it delivers first-quarter results just as a new U.S. legislative proposal threatens to sever a critical revenue stream from China.

The immediate focus is the quarterly report due April 15. Management, led by CEO Christophe Fouquet and CFO Roger Dassen, will detail performance against its Q1 forecast for net sales between €8.2 billion and €8.9 billion, with a gross margin of 51% to 53%. Analysts project earnings per share of $7.67. Beyond the headline numbers, investor attention will zero in on order bookings and executive commentary regarding customer investment sentiment, especially given recent industry volatility.

Simultaneously, regulatory pressure from Washington introduces fresh uncertainty. A bipartisan group of U.S. lawmakers has introduced the MATCH Act, legislation designed to significantly curtail China's access to chipmaking equipment. The bill would encompass ASML's deep ultraviolet (DUV) lithography systems, which have remained eligible for sale to Chinese clients. Specifically named companies like SMIC, Hua Hong, Huawei, CXMT, and YMTC would be barred from purchasing or servicing these machines.

The market reaction was swift, with ASML shares shedding 2.6% on news of the proposal. The company declined to comment, while the Dutch foreign ministry stated it does not comment on foreign legislative drafts. This development complicates ASML's existing guidance. In January, the firm projected China would account for only about 20% of its sales in 2026, down from 33% the prior year. That forecast preceded the MATCH Act. Bank of America analysts estimate that a full ban on immersion lithography tools could reduce ASML's revenue by 14-15% and EBIT by 16-17%. However, the legislative process is only just beginning.

Should investors sell immediately? Or is it worth buying Asml?

Offsetting this geopolitical headwind is a formidable order backlog exceeding €38 billion, more than half of which is for advanced extreme ultraviolet (EUV) systems. This buffer was recently bolstered by a landmark deal. In late March, SK Hynix announced an order for EUV equipment worth approximately $8 billion, the largest publicly disclosed single order from an ASML customer, with delivery scheduled through 2027.

The company's full-year outlook remains unchanged, targeting net sales of €34 billion to €39 billion. Looking further ahead, management's long-term ambition is to achieve annual revenue between €44 billion and €60 billion by 2030, with gross margins of 56% to 60%.

Following the earnings release, ASML's calendar remains packed. The annual general meeting is set for April 22 in Veldhoven. Key agenda items include the appointment of Marco Pieters as the new Chief Technology Officer for a four-year term and the reappointment of CFO Roger Dassen and COO Frédéric Schneider-Maunoury. Shareholders will also vote on a final dividend of €2.70 per share, part of a total proposed dividend of €7.50 per share for fiscal 2025—a 17% year-over-year increase. Payment is scheduled for April 24.

Asml at a turning point? This analysis reveals what investors need to know now.

This shareholder return program runs alongside an active buyback initiative. Between March 30 and April 3, ASML repurchased nearly 88,000 of its own shares for approximately €100 million. The broader program is authorized to spend up to €12 billion through 2028.

ASML's stock has climbed roughly 27% since the start of the year, trading well above its 200-day moving average. How CEO Christophe Fouquet addresses the dual challenges of meeting quarterly expectations and navigating the shifting regulatory landscape will likely set the tone for the weeks ahead.

Ad

Asml Stock: New Analysis - 13 April

Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Asml analysis...

So schätzen die Börsenprofis ASMLs Aktien ein!

<b>So schätzen die Börsenprofis ASMLs Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | NL0010273215 | ASMLS | boerse | 69137103 |